- $1.20bn
- $1.39bn
- $796.85m
GoodRx, PBMs accused of suppressing reimbursements to independent pharmacies
Brief: Ronald E. Bruehlman Joins GoodRx Board Of Directors
U.S. STOCKS ON THE MOVE-Duolingo, Beyond Meat, Oil stocks
U.S. STOCKS ON THE MOVE-Parker Hannifin, Corpay, Sezzle
GoodRx Holdings Inc reports results for the quarter ended in June - Earnings Summary
U.S. STOCKS ON THE MOVE-Datadog, Palantir, NRG Energy
U.S. STOCKS ON THE MOVE-Occidental Petroleum, Eli Lilly
GoodRx Holdings falls on lower quarterly net income
Brief: GoodRx Holdings Q2 Adjusted Net Income USD 32.4 Million Vs. IBES Estimate USD 33.9 Million
GoodRx Holdings Inc expected to post earnings of 9 cents a share - Earnings Preview
Boehringer-GoodRx partner to offer Humira rival at 92% discount
U.S. RESEARCH ROUNDUP-ACV Auctions, Asbury Automotive Group, Walmart
Brief: Simon Patterson Joins Goodrx Board Of Directors
U.S. RESEARCH ROUNDUP-Analog Devices, NVIDIA, Snowflake
GoodRx rallies as Raymond James upgrades following inaugural investor day
U.S. RESEARCH ROUNDUP-AN2 Therapeutics, Ecolab, RPM International
Brief: GoodRx and Kroger Sign Direct Contracting Agreement
GoodRx Holdings Inc reports results for the quarter ended in January - Earnings Summary
Brief: GoodRx Holdings Q1 Adjusted Net Income USD 32.6 Million Vs. IBES Estimate USD 31.3 Million